Cogstate Limited provided earnings guidance for the he full year ended 30 June 2023. For the year, the company expects revenue to be in the range of $39 million - $41 million (9% - 12% below FY22); EBIT, from normal operations, is expected to be in the range of $1.0 million - $2.0 million; Net Profit before Tax, including restructure costs and interest revenue, is expected to be in the range of $0.6 million - $1.6 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 AUD | 0.00% | +2.19% | -3.11% |
Apr. 01 | Cogstate Amends License Agreement with Eisai for Alzheimer’s Treatment | MT |
Feb. 22 | Cogstate's Fiscal H1 Attributable Profit Jumps, Revenue Rises 3%; Shares Decline 8% | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.11% | 158M | |
+21.34% | 47.9B | |
+46.56% | 41.42B | |
-2.27% | 40.7B | |
-6.20% | 28.92B | |
+10.70% | 25.55B | |
-21.40% | 19.27B | |
-2.00% | 12.15B | |
+31.05% | 12.14B | |
-0.78% | 11.99B |
- Stock Market
- Equities
- CGS Stock
- News Cogstate Limited
- Cogstate Limited Provides Revenue Guidance in the Fourth Quarter 2023